10/15/2026
Creative Biogene's integrated workflow connects therapeutic design, targeted lentiviral vector engineering, functional evaluation, translational studies, and GMP development to support the progression of in vivo CAR-T candidates toward IND-enabling development.
End-to-end lentiviral vector-based in vivo CAR-T development, from CAR design and targeted LVV engineering to in vivo validation, CMC, and analytical support.